Results 311 to 320 of about 431,916 (392)
Multivalently engineered glyco-nanoplatforms for targeted therapy and diagnostics. [PDF]
Zhang XL +4 more
europepmc +1 more source
A novel assay evaluates plant biostimulants targeting the brassinosteroid receptor BRI1, a central component in plant growth and development. By expressing BRI1 in fission yeast, functional activation by brassinolide (BL) was enabled. Transcriptomic profiling identified BL‐responsive genes, leading to a GFP‐based reporter system. This platform offers a
Maribel Marquina +9 more
wiley +1 more source
A cut above: atypical proteolysis endows complement C3 with non-canonical immune activities. [PDF]
West EE, Kemper C.
europepmc +1 more source
CLEC18A is a previously poorly characterized C‐type lectin. We mapped the expression of CLEC18A to the proximal tubule of the kidney and found CLEC18A to interact with sulfated glycosaminoglycans on proteoglycans. Furthermore, we found that CLEC18A plays an important role in hindering the progression of clear cell renal cell carcinomas in humans and in
Gustav Jonsson +10 more
wiley +1 more source
Do microenvironmental changes in degenerative disc disease reflect in systemic circulation? A proteomic investigation. [PDF]
Nayagam SM +10 more
europepmc +1 more source
Heteromeric cis‐prenyltransferases (CPT) are indispensable for dolichol synthesis and protein N‐glycosylation in most eukaryotes. The catalytic subunits are strongly conserved throughout evolution, in contrast to the evolutionarily variable accessory subunits. The POC1 protein from Paramecium tetraurelia is the smallest identified CPT‐accessory subunit
Agnieszka Onysk +8 more
wiley +1 more source
Agglutinin chip screening of B cell surface biomarkers in Hashimoto's thyroiditis for therapeutic targeting. [PDF]
Ren JL, Wang XM.
europepmc +1 more source

